Optimizing Patient-Specific Medication Regimen Policies Using Wearable Sensors in Parkinson's Disease

Matt Baucum, Anahita Khojandi, Rama Vasudevan, Ritesh Ramdhani

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Effective treatment of Parkinson's disease (PD) is a continual challenge for healthcare providers, and providers can benefit from leveraging emerging technologies to supplement traditional clinic care. We develop a data-driven reinforcement learning (RL) framework to optimize PD medication regimens through wearable sensors. We leverage a data set of n = 26 PD patients who wore wrist-mounted movement trackers for two separate six-day periods. Using these data, we first build and validate a simulation model of how individual patients' movement symptoms respond to medication administration. We then pair this simulation model with an on-policy RL algorithm that recommends optimal medication types, timing, and dosages during the day while incorporating human-in-the-loop considerations on medication administration. The results show that the RL-prescribed medication regimens outperform physicians' medication regimens, despite physicians having access to the same data as the RL agent. To validate our results, we assess our wearable-based RL medication regimens using n = 399 PD patients from the Parkinson's Progression Markers Initiative data set. We show that the wearable-based RL medication regimens would lead to significant symptom improvement for these patients, even more so than training RL policies directly from this data set. In doing so, we show that RL models from even small data sets of wearable data can offer novel, generalizable clinical insights and medication strategies, which may outperform those derived from larger data sets without wearable data.

Original languageEnglish
Pages (from-to)5964-5982
Number of pages19
JournalManagement Science
Volume69
Issue number10
DOIs
StatePublished - Oct 2023

Funding

The authors thank the anonymous associate editor and reviewers for their constructive and helpful comments. Data used in this article were obtained from the Parkinson Progression Markers Initiative (PPMI) database (www.ppmi-info.org/ access-data-specimens/download-data). PPMI is sponsored by the Michael J. Fox Foundation for Parkinson’s Research. Funding:This research is partially supported by the Science Alliance, University of Tennessee and by the Laboratory Directed Research and Development Program, Oak Ridge National Laboratory man-aged by UT-Battelle, LLC for the U.S. Department of Energy. Data used in this article were obtained from the Parkinson Progression Markers Initiative (PPMI) database, which is sponsored by the Michael J. Fox Foundation for Parkinson’s Research (MJFF).

FundersFunder number
Parkinson Progression Markers Initiative
Science Alliance
U.S. Department of Energy
Michael J. Fox Foundation for Parkinson's Research
Oak Ridge National Laboratory
University of Tennessee
UT-Battelle

    Keywords

    • PPMI
    • chronic disease management
    • reinforcement learning
    • remote monitoring
    • wearable sensors

    Fingerprint

    Dive into the research topics of 'Optimizing Patient-Specific Medication Regimen Policies Using Wearable Sensors in Parkinson's Disease'. Together they form a unique fingerprint.

    Cite this